Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ksherwood
    Junior Member
    • Apr 2011
    • 4

    #1

    baySeq

    Hi,
    I would appreciate some help from anyone out there that might be able to assist!

    I am using baySeq to analyse the DGE-tag illumina sequenced data. I have also used DESeq and edgeR. I am trying to identify how similar the results using all three methods are.

    However I would like to know how to modify the PLOTMA in baySeq? In the simulated data example, the PLOTMA is shown as;

    > plotMA.CD(CD, samplesA = 1:5, samplesB = 6:10, col = c(rep("red",
    + 100), rep("black", 900)))

    However, the colours are set as red for the 100 data points which have been simulated to be DE ("The data are simulated such that the first hundred counts show di fferential expression between the first five libraries and the second five libraries.").

    Obviously I don't know which data points in my data sets will be DE- how to I produce the plotMA which colours, say, the top 100 most significantly DE genes? I am able to produce the plotMA graph with no colours.

    thank you in advance for your help,
  • biokari
    Junior Member
    • Feb 2011
    • 4

    #2
    I have the same problem, help!!!!!

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      The general idea is to sort the p-value/logFC/whatever that you want to color by, select the 100th (or whatever) highest/lowest value from that, and then use ifelse() to do the coloring. The following is some basic R pseudo-code, since I don't use baySeq:

      Code:
      threshold <- sort(abs(logFC),partial=length(logFC)-100, decreasing=T)[length(logFC)-100]
      plotMA.CD(CD, samplesA = 1:5, samplesB = 6:10, col = ifelse(abs(logFC) >= threshold, "red", "black"))

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:22 PM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...